VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers
Childhood cancer: The surprising scientific facts
Current and future status of cancer care in Calmette Hospital
Choosing Wisely in medical oncology
Hemopathy burden at National Cancer Center
Role of radiation therapy in preventing handicap
To avoid unnecessary second surgery in differentiated thyroid cancer
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma
Cancer Survivorship
Cancer Care in Older Adults and Special Population
The clinical impact of the Choosing Wisely project